Unassociated Document

FORM 6-K
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
 
dated October 26, 2009
 
Commission File Number 0-51504
 
GENETIC TECHNOLOGIES LIMITED
(Exact Name as Specified in its Charter)
 
       N/A       
(Translation of Registrant’s Name)
 
60-66 Hanover Street
Fitzroy
Victoria 3065 Australia
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F  x           Form 40-F ¨
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
 
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes ¨                        No x
 
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):  Not applicable.
 
 
 
 
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused the Report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date:  October 26, 2009
  
   
 
GENETIC TECHNOLOGIES LIMITED
   
   
 
By: 
/s/ Thomas Howitt
   
Name:  
Thomas Howitt
   
Title:
Chief Financial Officer

 
 
 

EXHIBIT INDEX
 
Exhibit
  
Description of Exhibit
     
99.1
  
2009 Notice of Annual General Meeting
     
99.2
  
2009 Annual Report
     
99.3
  
ASX Announcement October 23,2009